Related Experiment Video
Updated: Mar 26, 2026

09:28
Automated High-throughput Behavioral Analyses in Zebrafish Larvae
Published on: July 4, 2013
15.9K
Leveraging Large-scale Behavioral Profiling in Zebrafish to Explore Neuroactive Polypharmacology
Matthew N McCarroll1, Leo Gendelev1, Michael J Keiser1
1University of California San Francisco , Institute of Neurodegenerative Diseases, 675 Nelson Rising Lane, San Francisco, California 94143, United States.
ACS Chemical Biology
|February 5, 2016
Summary
Identifying new psychiatric drugs is challenging due to complex mechanisms. Zebrafish behavioral screening offers a novel approach to discover compounds with polypharmacology for developing central nervous system (CNS) therapeutics.
Area of Science:
- Neuroscience
- Pharmacology
- Genetics
Background:
- Psychiatric medications often target multiple pathways in the nervous system.
- Traditional in vitro screening methods struggle to identify these multitarget compounds.
- Complex polypharmacology is a key feature of many effective psychiatric drugs.
Purpose of the Study:
- To explore novel methods for identifying multitarget compounds for psychiatric drug discovery.
- To leverage phenotypic profiling in zebrafish for identifying compounds with complex polypharmacology.
- To establish a framework for linking behavioral screening data with target pathway predictions.
Main Methods:
- Utilized large-scale, behavior-based chemical screens in zebrafish.
- Performed systems-level structural analysis of identified compounds.
- Applied statistical methods to predict enriched target pathways.
Main Results:
- Successfully identified a large number of structurally diverse, phenotype-related compounds.
- Demonstrated the feasibility of rapid compound identification through behavioral assays.
- Developed a method to predict potential multitarget pathways from compound structures.
Conclusions:
- Systematic behavioral profiling in zebrafish is a powerful tool for discovering novel psychiatric drug candidates.
- Integrating behavioral screening with multitarget predictions can accelerate the identification of new central nervous system (CNS) therapeutics.
- This approach facilitates the discovery of new behavior-modifying pathways.

